Name: MIRA Pharmaceuticals, Inc. (MIRA) Financial Statements
Creator: FinSpry

MIRA Pharmaceuticals Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

MIRA Pharmaceuticals, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	0.00	0.00	0.00	0.00	0.00
Cost of Revenue	0.00	0.00	0.00	0.00	0.00
Gross Profit	0.00	0.00	0.00	0.00	0.00
Operating Expenses
Research & Development	3.31	1.57	2.35	0.68	0.04
Selling, General & Administrative	4.71	6.95	4.70	1.47	0.16
Operating Expenses	8.02	8.53	7.05	2.15	0.20
Operating Income	-8.02	-8.53	-7.05	-2.15	-0.20
Other Income/Expense
Interest Income	0.00	0.00	0.00	0.00	0.00
Interest Expense	0.17	-3.46	-0.01	-0.02	0.00
Other Income/Expense	0.17	0.00	0.00	0.00	0.00
Income
Income Before Tax	-7.85	-11.98	-7.06	-2.18	-0.20
Income Tax Expense	0.00	0.00	0.00	0.00	0.00
Net Income	-7.85	-11.98	-7.06	-2.18	-0.20
Net Income - Continuous Operations	-7.85	-11.98	-7.06	-2.18	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-8.02	-8.53	-7.05	-2.15	0.00
EBIT	-8.02	-8.53	-7.05	-2.15	-0.20
Depreciation & Amortization	0.00	0.00	0.00	0.00	0.00
Earnings Per Share
Basic EPS	-1.00	-1.00	-	-	-
Diluted EPS	-1.00	-1.00	-	-	-
Basic Shares Outstanding	15.44	13.92	17.57	12.67	0.00
Diluted Shares Outstanding	15.44	13.92	17.57	12.67	0.00